Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation. Issues related to COVID-19 stimulus legislation.
Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation.
Duration: January 1, 2016
to
August 1, 2020
General Issues: Health Issues , Medicare/Medicaid , Budget/Appropriations , Pharmacy , Taxation/Internal Revenue Code
Spending: about $910,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2016: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Labor - Dept of (DOL), White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Treasury - Dept of
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Jeff MacKinnon LD and LA Rep. Joe Barton (R-Texas)
LD & LA Rep. Joe Barton (RTexas)
Jeff Mortier Prof Staff on E&C Cmte and LA Rep Whitfield
Prof Staff on E&C Cmte, LA Rep Whitfield and Intern
Devin Nunes
Joseph Vasapoli Min.Counsel, Energy&Comm, Special Asst. DOE
Min.Counsel, Energy&Comm, Special Asst. DOE
Min. Counsel, Energy&Comm, Special Asst. DOE
Jeffery Mortier Prof Staff on E&C Cmte and LA Rep Whitfield, Intern for Devin Nunes
Prof Staff on E&C Cmte, LA Rep Whitfield and Intern
Devin Nunes
Jeffrey MacKinnon LD and LA Rep. Joe Barton (R-Texas)
Sarah Walter Former Legislative Director/Chief Counsel, Sen. John Breaux
J. Daniel Walsh LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner
Edward Whitfield U.S. Representative (21 yrs.)
Kristen O'Neill Health Policy Advisory, LA, Staff Assistant Gene Greene (D-TX)
Staff Assistant GK Butterfield (D-NC)
Jody Gale n/a
William Krieger n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
3rd Quarter, 2020
Farragut Partners LLP terminated an engagement in which they represented Blue Cross Blue Shield Association on Oct. 19, 2020.
Original Filing: 301215621.xml
Lobbying Issues
Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation. Issues related to COVID-19 stimulus legislation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on July 20, 2020.
Original Filing: 301198083.xml
Lobbying Issues
Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation. Issues related to COVID-19 stimulus legislation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
Farragut Partners LLP amended a lobbying report for representation of Blue Cross Blue Shield Association in Q12020 on May 4, 2020.
Original Filing: 301181932.xml
Lobbying Issues
Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation. Issues related to COVID-19 stimulus legislation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on April 20, 2020.
Original Filing: 301174407.xml
Lobbying Issues
Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation. Issues related to COVID-19 stimulus legislation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation.
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on Jan. 17, 2020.
Original Filing: 301109442.xml
Lobbying Issues
Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
3rd Quarter, 2019
In Q3, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on Oct. 18, 2019.
Original Filing: 301069330.xml
Lobbying Issues
Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
2nd Quarter, 2019
In Q2, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on July 18, 2019.
Original Filing: 301049163.xml
Lobbying Issues
Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
1st Quarter, 2019
In Q1, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on April 17, 2019.
Original Filing: 301026923.xml
Lobbying Issues
Affordable Care Act Issues: Small group expansion Risk Corridors Delivery system reform Consumer experience Back end issues
Implementation issues Regulations Premiums Exchanges Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity Medicare Advantage Reinsurance Health care quality issues Community health
management Siteneutral
Payments Dialysis care funding mechanism Patient reform Payment reform Opioid abuse Medical
Loss Ratios Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs
to be included in the coverage options offered by OPM Alternative structures for the FEHBM.
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings Government contribution to FEHBP premiums
Reinsurance Regional PPO Language H.R. 1624 Protecting Affordable Coverage of Employees Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas Medicare A & B Delivery System Reforms Benefit Restructuring
Medigap Medicare Advantage Risk Delay Community Health Management Medicare fraud Cybersecurity ICD10
Medicare Prescription Drug Integrity Provider directories
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on Jan. 16, 2019.
Original Filing: 301005239.xml
Lobbying Issues
Affordable Care Act Issues: Small group expansion Risk Corridors Delivery system reform Consumer experience Back end issues Implementation issues Regulations Premiums Exchanges Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity Medicare Advantage Reinsurance Health care quality issues Community health management Siteneutral
Payments Dialysis care funding mechanism Patient reform Payment reform Opioid abuse Medical
Loss Ratios Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs
to be included in the coverage options offered by OPM Alternative structures for the FEHBM.
Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the
Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a
program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified.
States with flexibility in determining the size of employers in the small group market
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings Government contribution to FEHBP premiums
Reinsurance Regional PPO Language
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of 21st Century Cures
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas Medicare A & B Delivery System Reforms Benefit Restructuring
Medigap Medicare Advantage Risk Delay Community Health Management Medicare fraud Cybersecurity ICD10
Medicare Prescription Drug Integrity Provider directories
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax IRC section 833(b) tax provisions Medical Loss Ratio definition to qualify for 833(b) tax deduction Tax ID
number reporting Cadillac tax Tax extenders Device tax repeal Tax reform
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2018
In Q3, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on Oct. 18, 2018.
Original Filing: 300989087.xml
Lobbying Issues
Affordable Care Act Issues: Small group expansion Risk Corridors Delivery system reform Consumer experience Back end issues Implementation issues Regulations Premiums Exchanges Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity Medicare Advantage Reinsurance Health care quality issues Community health management Siteneutral
Payments Dialysis care funding mechanism Patient reform Payment reform Opioid abuse Medical
Loss Ratios Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs
to be included in the coverage options offered by OPM Alternative structures for the FEHBM.
Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the
Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a
program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified.
States with flexibility in determining the size of employers in the small group market
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings Government contribution to FEHBP premiums
Reinsurance Regional PPO Language H.R. 1624 Protecting Affordable Coverage of Employees Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Laboratory developed tests
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk, highreward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas Medicare A & B Delivery System Reforms Benefit Restructuring
Medigap Medicare Advantage Risk Delay Community Health Management Medicare fraud Cybersecurity ICD10
Medicare Prescription Drug Integrity Provider directories
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax IRC section 833(b) tax provisions Medical Loss Ratio definition to qualify for 833(b) tax deduction Tax ID
number reporting Cadillac tax Tax extenders Device tax repeal Tax reform
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2018
In Q2, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on July 19, 2018.
Original Filing: 300971385.xml
Lobbying Issues
Affordable Care Act Issues: Small group expansion Risk Corridors Delivery system reform Consumer experience Back end issues Implementation issues Regulations Premiums Exchanges Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity Medicare Advantage Reinsurance Health care quality issues Community health management Siteneutral
Payments Dialysis care funding mechanism Patient reform Payment reform Opioid abuse Medical
Loss Ratios Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs
to be included in the coverage options offered by OPM Alternative structures for the FEHBM.
Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the
Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a
program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified.
States with flexibility in determining the size of employers in the small group market
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings Government contribution to FEHBP premiums
Reinsurance Regional PPO Language H.R. 1624 Protecting Affordable Coverage of Employees Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Laboratory developed tests
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk, highreward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas Medicare A & B Delivery System Reforms Benefit Restructuring
Medigap Medicare Advantage Risk Delay Community Health Management Medicare fraud Cybersecurity ICD10
Medicare Prescription Drug Integrity Provider directories
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax IRC section 833(b) tax provisions Medical Loss Ratio definition to qualify for 833(b) tax deduction Tax ID
number reporting Cadillac tax Tax extenders Device tax repeal Tax reform
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2018
In Q1, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on April 18, 2018.
Original Filing: 300947564.xml
Lobbying Issues
Affordable Care Act Issues: Small group expansion Risk Corridors Delivery system reform Consumer experience Back end issues Implementation issues Regulations Premiums Exchanges Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity Medicare Advantage Reinsurance Health care quality issues Community health management Siteneutral
Payments Dialysis care funding mechanism Patient reform Payment reform Opioid abuse Medical
Loss Ratios Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs
to be included in the coverage options offered by OPM Alternative structures for the FEHBM.
Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the
Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a
program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified.
States with flexibility in determining the size of employers in the small group market
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings Government contribution to FEHBP premiums
Reinsurance Regional PPO Language H.R. 1624 Protecting Affordable Coverage of Employees Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Laboratory developed tests
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk, highreward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas Medicare A & B Delivery System Reforms Benefit Restructuring
Medigap Medicare Advantage Risk Delay Community Health Management Medicare fraud Cybersecurity ICD10
Medicare Prescription Drug Integrity Provider directories
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax IRC section 833(b) tax provisions Medical Loss Ratio definition to qualify for 833(b) tax deduction Tax ID
number reporting Cadillac tax Tax extenders Device tax repeal Tax reform
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2017
In Q4, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on Jan. 11, 2018.
Original Filing: 300922778.xml
Lobbying Issues
Affordable Care Act Issues: Small group expansion Risk Corridors Delivery system reform Consumer experience Back end issues Implementation issues Regulations Premiums Exchanges Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity Medicare Advantage Reinsurance Health care quality issues Community health management Siteneutral
Payments Dialysis care funding mechanism Patient reform Payment reform Opioid abuse Medical
Loss Ratios Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs
to be included in the coverage options offered by OPM Alternative structures for the FEHBM.
S 123 Introduced January 8, 2015 by Marco Rubio (RFL)
Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the
Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a
program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified.
S. 1099 Introduced April 27, 2015 by Tim Scott (RSC)
A bill to amend the Patient Protection and Affordable Care Act to provide
States with flexibility in determining the size of employers in the small group market
HR 221 Introduced January 8, 2015 by Andy Harris (RMD)
Taxpayer bailout of health insurers
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
This bill repeals a provision of the Patient Protection and
Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (RKY)
To amend title I of the Patient Protection and Affordable Care Act and
title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings Government contribution to FEHBP premiums
Reinsurance Regional PPO Language H.R. 1624 Protecting Affordable Coverage of Employees Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Laboratory developed tests
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk, highreward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas Medicare A & B Delivery System Reforms Benefit Restructuring
Medigap Medicare Advantage Risk Delay Community Health Management Medicare fraud Cybersecurity ICD10
Medicare Prescription Drug Integrity Provider directories
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan, early stage investigators, and highrisk, highreward research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs.
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax IRC section 833(b) tax provisions Medical Loss Ratio definition to qualify for 833(b) tax deduction Tax ID
number reporting Cadillac tax Tax extenders Device tax repeal Tax reform
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
S 183 Introduced January 16, 2015 by John Barrasso (RWY)
Jobs and Premium Protection Act This bill repeals a provision of the
Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2017
In Q3, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on Oct. 20, 2017.
Original Filing: 300914680.xml
Lobbying Issues
Affordable Care Act Issues: Small group expansion Risk Corridors Delivery system reform Consumer experience Back end issues Implementation issues Regulations Premiums Exchanges Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity Medicare Advantage Reinsurance Health care quality issues Community health management Siteneutral
Payments Dialysis care funding mechanism Patient reform Payment reform Opioid abuse Medical
Loss Ratios Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs
to be included in the coverage options offered by OPM Alternative structures for the FEHBM.
S 123 Introduced January 8, 2015 by Marco Rubio (RFL)
Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the
Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a
program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified.
S. 1099 Introduced April 27, 2015 by Tim Scott (RSC)
A bill to amend the Patient Protection and Affordable Care Act to provide
States with flexibility in determining the size of employers in the small group market
HR 221 Introduced January 8, 2015 by Andy Harris (RMD)
Taxpayer bailout of health insurers
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
This bill repeals a provision of the Patient Protection and
Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (RKY)
To amend title I of the Patient Protection and Affordable Care Act and
title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings Government contribution to FEHBP premiums
Reinsurance Regional PPO Language H.R. 1624 Protecting Affordable Coverage of Employees Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Laboratory developed tests
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk, highreward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas Medicare A & B Delivery System Reforms Benefit Restructuring
Medigap Medicare Advantage Risk Delay Community Health Management Medicare fraud Cybersecurity ICD10
Medicare Prescription Drug Integrity Provider directories
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan, early stage investigators, and highrisk, highreward research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs.
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax IRC section 833(b) tax provisions Medical Loss Ratio definition to qualify for 833(b) tax deduction Tax ID
number reporting Cadillac tax Tax extenders Device tax repeal Tax reform
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
S 183 Introduced January 16, 2015 by John Barrasso (RWY)
Jobs and Premium Protection Act This bill repeals a provision of the
Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2017
In Q2, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on July 20, 2017.
Original Filing: 300895932.xml
Lobbying Issues
Affordable Care Act Issues: Small group expansion Risk Corridors Delivery system reform Consumer experience Back end issues Implementation issues Regulations Premiums Exchanges Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity Medicare Advantage Reinsurance Health care quality issues Community health management Siteneutral
Payments Dialysis care funding mechanism Patient reform Payment reform Opioid abuse Medical
Loss Ratios Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs
to be included in the coverage options offered by OPM Alternative structures for the FEHBM.
S 123 Introduced January 8, 2015 by Marco Rubio (RFL)
Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the
Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a
program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified.
S. 1099 Introduced April 27, 2015 by Tim Scott (RSC)
A bill to amend the Patient Protection and Affordable Care Act to provide
States with flexibility in determining the size of employers in the small group market
HR 221 Introduced January 8, 2015 by Andy Harris (RMD)
Taxpayer bailout of health insurers
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
This bill repeals a provision of the Patient Protection and
Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (RKY)
To amend title I of the Patient Protection and Affordable Care Act and
title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings Government contribution to FEHBP premiums
Reinsurance Regional PPO Language H.R. 1624 Protecting Affordable Coverage of Employees Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Laboratory developed tests
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk, highreward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas Medicare A & B Delivery System Reforms Benefit Restructuring
Medigap Medicare Advantage Risk Delay Community Health Management Medicare fraud Cybersecurity ICD10
Medicare Prescription Drug Integrity Provider directories
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan, early stage investigators, and highrisk, highreward research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs.
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax IRC section 833(b) tax provisions Medical Loss Ratio definition to qualify for 833(b) tax deduction Tax ID
number reporting Cadillac tax Tax extenders Device tax repeal Tax reform
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
S 183 Introduced January 16, 2015 by John Barrasso (RWY)
Jobs and Premium Protection Act This bill repeals a provision of the
Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2017
In Q1, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on April 20, 2017.
Original Filing: 300877266.xml
Lobbying Issues
Affordable Care Act Issues: Small group expansion Risk Corridors Delivery system reform Consumer experience Back end issues Implementation issues Regulations Premiums Exchanges Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity Medicare Advantage Reinsurance Health care quality issues Community health management Siteneutral
Payments Dialysis care funding mechanism Patient reform Payment reform Opioid abuse Medical
Loss Ratios Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs
to be included in the coverage options offered by OPM Alternative structures for the FEHBM.
S 123 Introduced January 8, 2015 by Marco Rubio (RFL)
Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the
Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a
program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified.
S. 1099 Introduced April 27, 2015 by Tim Scott (RSC)
A bill to amend the Patient Protection and Affordable Care Act to provide
States with flexibility in determining the size of employers in the small group market
HR 221 Introduced January 8, 2015 by Andy Harris (RMD)
Taxpayer bailout of health insurers
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
This bill repeals a provision of the Patient Protection and
Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (RKY)
To amend title I of the Patient Protection and Affordable Care Act and
title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings Government contribution to FEHBP premiums
Reinsurance Regional PPO Language H.R. 1624 Protecting Affordable Coverage of Employees Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Laboratory developed tests
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk,
highreward
research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for
21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas Medicare A & B Delivery System Reforms Benefit Restructuring
Medigap Medicare Advantage Risk Delay Community Health Management Medicare fraud Cybersecurity ICD10
Medicare
Prescription Drug Integrity Provider directories
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk,
highreward
research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for
21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs.
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax IRC section 833(b) tax provisions Medical Loss Ratio definition to qualify for 833(b) tax deduction Tax ID
number reporting Cadillac tax Tax extenders Device tax repeal Tax reform
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
S 183 Introduced January 16, 2015 by John Barrasso (RWY)
Jobs and Premium Protection Act This bill repeals a provision of the
Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2016
In Q4, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on Jan. 23, 2017.
Original Filing: 300857664.xml
Lobbying Issues
Affordable Care Act Issues: Small group expansion Risk Corridors Delivery system reform Consumer experience Back end issues
Implementation issues Regulations Premiums Exchanges Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity Medicare Advantage Reinsurance Health care quality issues Community
health management Siteneutral
Payments Dialysis care funding mechanism Patient reform Payment reform Opioid abuse Medical
Loss Ratios Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs
to be included in the coverage options offered by OPM Alternative structures for the FEHBM.
S 123 Introduced January 8, 2015 by Marco Rubio (RFL)
Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the
Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a
program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified.
S. 1099 Introduced April 27, 2015 by Tim Scott (RSC)
A bill to amend the Patient Protection and Affordable Care Act to provide
States with flexibility in determining the size of employers in the small group market
HR 221 Introduced January 8, 2015 by Andy Harris (RMD)
Taxpayer bailout of health insurers
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
This bill repeals a provision of the Patient Protection and
Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (RKY)
To amend title I of the Patient Protection and Affordable Care Act and
title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings Government contribution to FEHBP premiums Reinsurance Regional PPO Language H.R. 1624 Protecting Affordable Coverage of Employees Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Laboratory developed tests
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk,
highreward
research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for
21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas Medicare A & B Delivery System Reforms Benefit Restructuring
Medigap Medicare Advantage Risk Delay Community Health Management Medicare fraud Cybersecurity ICD10
Medicare
Prescription Drug Integrity Provider directories
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk,
highreward
research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for
21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs.
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax IRC section 833(b) tax provisions Medical Loss Ratio definition to qualify for 833(b) tax deduction Tax ID
number reporting Cadillac tax Tax extenders Device tax repeal Tax reform
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
S 183 Introduced January 16, 2015 by John Barrasso (RWY)
Jobs and Premium Protection Act This bill repeals a provision of the
Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2016
In Q3, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on Oct. 20, 2016.
Original Filing: 300838899.xml
Lobbying Issues
Affordable Care Act Issues: Small group expansion Risk Corridors Delivery system reform Consumer experience Back end issues
Implementation issues Regulations Premiums Exchanges Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity Medicare Advantage Reinsurance Health care quality issues Community
health management Siteneutral
Payments Dialysis care funding mechanism Patient reform Payment reform Opioid abuse Medical
Loss Ratios Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs
to be included in the coverage options offered by OPM Alternative structures for the FEHBM.
S 123 Introduced January 8, 2015 by Marco Rubio (RFL)
Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the
Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a
program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified.
S. 1099 Introduced April 27, 2015 by Tim Scott (RSC)
A bill to amend the Patient Protection and Affordable Care Act to provide
States with flexibility in determining the size of employers in the small group market
HR 221 Introduced January 8, 2015 by Andy Harris (RMD)
Taxpayer bailout of health insurers
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
This bill repeals a provision of the Patient Protection and
Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (RKY)
To amend title I of the Patient Protection and Affordable Care Act and
title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings Government contribution to FEHBP premiums Reinsurance Regional PPO Language H.R. 1624 Protecting Affordable Coverage of Employees Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Laboratory developed tests
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk,
highreward
research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for
21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas Medicare A & B Delivery System Reforms Benefit Restructuring
Medigap Medicare Advantage Risk Delay Community Health Management Medicare fraud Cybersecurity ICD10
Medicare
Prescription Drug Integrity Provider directories
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk,
highreward
research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for
21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs.
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax IRC section 833(b) tax provisions Medical Loss Ratio definition to qualify for 833(b) tax deduction Tax ID
number reporting Cadillac tax Tax extenders Device tax repeal Tax reform
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
S 183 Introduced January 16, 2015 by John Barrasso (RWY)
Jobs and Premium Protection Act This bill repeals a provision of the
Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2016
In Q2, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on July 20, 2016.
Original Filing: 300820519.xml
Lobbying Issues
Affordable Care Act Issues: Small group expansion Risk Corridors Delivery system reform Consumer experience Back end issues
Implementation issues Regulations Premiums Exchanges Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity Medicare Advantage Reinsurance Health care quality issues Community
health management Siteneutral
Payments Dialysis care funding mechanism Patient reform Payment reform Opioid abuse Medical
Loss Ratios Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs
to be included in the coverage options offered by OPM Alternative structures for the FEHBM.
S 123 Introduced January 8, 2015 by Marco Rubio (RFL)
Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the
Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a
program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified.
S. 1099 Introduced April 27, 2015 by Tim Scott (RSC)
A bill to amend the Patient Protection and Affordable Care Act to provide
States with flexibility in determining the size of employers in the small group market
HR 221 Introduced January 8, 2015 by Andy Harris (RMD)
Taxpayer bailout of health insurers
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
This bill repeals a provision of the Patient Protection and
Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (RKY)
To amend title I of the Patient Protection and Affordable Care Act and
title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings Government contribution to FEHBP premiums Reinsurance Regional PPO Language H.R. 1624 Protecting Affordable Coverage of Employees Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Laboratory developed tests
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk,
highreward
research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for
21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas Medicare A & B Delivery System Reforms Benefit Restructuring
Medigap Medicare Advantage Risk Delay Community Health Management Medicare fraud Cybersecurity ICD10
Medicare
Prescription Drug Integrity Provider directories
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk,
highreward
research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for
21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs.
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax IRC section 833(b) tax provisions Medical Loss Ratio definition to qualify for 833(b) tax deduction Tax ID
number reporting Cadillac tax Tax extenders Device tax repeal Tax reform
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
S 183 Introduced January 16, 2015 by John Barrasso (RWY)
Jobs and Premium Protection Act This bill repeals a provision of the
Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2016
Farragut Partners LLP filed a lobbying registration on Nov. 7, 2017 to represent Blue Cross Blue Shield Association, effective Jan. 1, 2016.
Original Filing: 300918918.xml
Issue(s) they said they’d lobby about: Affordable Care Act Issues; 21st Century Cures; Health Insurance Tax .
1st Quarter, 2016
In Q1, Farragut Partners LLP lobbied for Blue Cross Blue Shield Association , earning $50,000. The report was filed on April 20, 2016.
Original Filing: 300801968.xml
Lobbying Issues
Affordable Care Act Issues: Small group expansion Risk Corridors Delivery system reform Consumer experience Back end issues
Implementation issues Regulations Premiums Exchanges Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity Medicare Advantage Reinsurance Health care quality issues Community
health management Siteneutral
Payments Dialysis care funding mechanism Patient reform Payment reform Opioid abuse Medical
Loss Ratios Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs
to be included in the coverage options offered by OPM Alternative structures for the FEHBM.
S 123 Introduced January 8, 2015 by Marco Rubio (RFL)
Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the
Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a
program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified.
S. 1099 Introduced April 27, 2015 by Tim Scott (RSC)
A bill to amend the Patient Protection and Affordable Care Act to provide
States with flexibility in determining the size of employers in the small group market
HR 221 Introduced January 8, 2015 by Andy Harris (RMD)
Taxpayer bailout of health insurers
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
This bill repeals a provision of the Patient Protection and
Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (RKY)
To amend title I of the Patient Protection and Affordable Care Act and
title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings Government contribution to FEHBP premiums Reinsurance Regional PPO Language H.R. 1624 Protecting Affordable Coverage of Employees Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Laboratory developed tests
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk,
highreward
research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for
21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas Medicare A & B Delivery System Reforms Benefit Restructuring
Medigap Medicare Advantage Risk Delay Community Health Management Medicare fraud Cybersecurity ICD10
Medicare
Prescription Drug Integrity Provider directories
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk,
highreward
research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for
21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs.
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax IRC section 833(b) tax provisions Medical Loss Ratio definition to qualify for 833(b) tax deduction Tax ID
number reporting Cadillac tax Tax extenders Device tax repeal Tax reform
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
S 183 Introduced January 16, 2015 by John Barrasso (RWY)
Jobs and Premium Protection Act This bill repeals a provision of the
Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2016
Farragut Partners LLP filed a lobbying registration on Feb. 12, 2016 to represent Blue Cross Blue Shield Association, effective Jan. 1, 2016.
Original Filing: 300786517.xml
Issue(s) they said they’d lobby about: Affordable Care Act Issues; 21st Century Cures; Health Insurance Tax .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...